Boxer R J, Kaufman J J, Goodwin W E
J Urol. 1977 Feb;117(2):208-13. doi: 10.1016/s0022-5347(17)58402-5.
Surgical therapy for early adenocarcinoma of the prostate has been an effective mode of cure since it was described by Young in 1905. The retropubic and perineal approaches of radical prostatectomy have been used at our hospitals for 25 years. Herein we examine 329 cases at the 2 hospitals. Although there were only 2 deaths (0.61 per cent) immediately attributable to the operation the surgical morbidity was significant. Patients of the attending staff had a 46 per cent complication rate while that of patients of the resident staff was 59 per cent. The 5 and 10-year survival rates of patients with stages A and B prostatic adenocarcinoma were 82 and 63 per cent, respectively, and the 5 and 10-year survival rates of patients who had stage C prostatic adenocarcinoma were 67 and 29 per cent, respectively. Our survival rates compare favorably to the national average survival for patients of all ages with localized or regional adenocarcinoma of the prostate. We believe that these data support the position of urologists who believe in radical surgical treatment of prostatic cancer.
自1905年扬描述以来,手术治疗早期前列腺腺癌一直是一种有效的治愈方式。耻骨后和会阴根治性前列腺切除术已在我们医院使用了25年。在此,我们对两家医院的329例病例进行了研究。尽管仅有2例死亡(0.61%)直接归因于手术,但手术并发症发生率很高。主治医生负责的患者并发症发生率为46%,而住院医生负责的患者并发症发生率为59%。A期和B期前列腺腺癌患者的5年和10年生存率分别为82%和63%,C期前列腺腺癌患者的5年和10年生存率分别为67%和29%。我们的生存率与所有年龄局限性或区域性前列腺腺癌患者的全国平均生存率相比具有优势。我们认为这些数据支持了相信前列腺癌根治性手术治疗的泌尿科医生的观点。